BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 27240160)

  • 21. Activatable near infrared dye conjugated hyaluronic acid based nanoparticles as a targeted theranostic agent for enhanced fluorescence/CT/photoacoustic imaging guided photothermal therapy.
    Liang X; Fang L; Li X; Zhang X; Wang F
    Biomaterials; 2017 Jul; 132():72-84. PubMed ID: 28411450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioactive MOFs Based Theranostic Agent for Highly Effective Combination of Multimodal Imaging and Chemo-Phototherapy.
    Zhu Y; Xin N; Qiao Z; Chen S; Zeng L; Zhang Y; Wei D; Sun J; Fan H
    Adv Healthc Mater; 2020 Jul; 9(14):e2000205. PubMed ID: 32548979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor.
    Li Y; Jiang C; Zhang D; Wang Y; Ren X; Ai K; Chen X; Lu L
    Acta Biomater; 2017 Jan; 47():124-134. PubMed ID: 27721008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatible PEGylated bismuth nanocrystals: "All-in-one" theranostic agent with triple-modal imaging and efficient in vivo photothermal ablation of tumors.
    Li Z; Liu J; Hu Y; Li Z; Fan X; Sun Y; Besenbacher F; Chen C; Yu M
    Biomaterials; 2017 Oct; 141():284-295. PubMed ID: 28709019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multifunctional theranostic contrast agent for ultrasound/near infrared fluorescence imaging-based tumor diagnosis and ultrasound-triggered combined photothermal and gene therapy.
    Wang L; Lu H; Gao Q; Yuan C; Ding F; Li J; Zhang D; Ou X
    Acta Biomater; 2019 Nov; 99():373-386. PubMed ID: 31525534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PDA-coated CPT@MIL-53(Fe)-based theranostic nanoplatform for pH-responsive and MRI-guided chemotherapy.
    Zhou C; Yang Q; Zhou X; Jia N
    J Mater Chem B; 2022 Mar; 10(11):1821-1832. PubMed ID: 35201249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controllable synthesis of rare earth (Gd
    Xu M; Chi B; Han Z; He Y; Tian F; Xu Z; Li L; Wang J
    Dalton Trans; 2020 Sep; 49(35):12327-12337. PubMed ID: 32844843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites.
    Yang H; Chen Y; Chen Z; Geng Y; Xie X; Shen X; Li T; Li S; Wu C; Liu Y
    Biomater Sci; 2017 May; 5(5):1001-1013. PubMed ID: 28327716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic-responsive and targeted cancer nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy.
    Guo Y; Ran Y; Wang Z; Cheng J; Cao Y; Yang C; Liu F; Ran H
    Biomaterials; 2019 Oct; 219():119370. PubMed ID: 31357006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Core-shell structured hollow copper sulfide@metal-organic framework for magnetic resonance imaging guided photothermal therapy in second near-infrared biological window.
    He J; Ramachandraiah K; Huang T; Yuan T; Liu X; Zhang H; Ke F
    Biochem Biophys Res Commun; 2023 Jan; 638():51-57. PubMed ID: 36436342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodegradable nanotheranostics with hyperthermia-induced bubble ability for ultrasound imaging-guided chemo-photothermal therapy.
    Xu C; Gao F; Wu J; Niu S; Li F; Jin L; Shi Q; Du L
    Int J Nanomedicine; 2019; 14():7141-7153. PubMed ID: 31564870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hybrid anisotropic nanostructures for dual-modal cancer imaging and image-guided chemo-thermo therapies.
    Zhang R; Cheng K; Antaris AL; Ma X; Yang M; Ramakrishnan S; Liu G; Lu A; Dai H; Tian M; Cheng Z
    Biomaterials; 2016 Oct; 103():265-277. PubMed ID: 27394161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copper Manganese Sulfide Nanoplates: A New Two-Dimensional Theranostic Nanoplatform for MRI/MSOT Dual-Modal Imaging-Guided Photothermal Therapy in the Second Near-Infrared Window.
    Ke K; Yang W; Xie X; Liu R; Wang LL; Lin WW; Huang G; Lu CH; Yang HH
    Theranostics; 2017; 7(19):4763-4776. PubMed ID: 29187902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HP-β-CD Functionalized Fe
    Song S; Chong Y; Fu H; Ning X; Shen H; Zhang Z
    ACS Appl Mater Interfaces; 2018 Oct; 10(40):33867-33878. PubMed ID: 30215249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-Responsive Carbon Dot for pH/Redox-Triggered Fluorescence Imaging with Controllable Photothermal Ablation Therapy of Cancer.
    Choi CA; Lee JE; Mazrad ZAI; Kim YK; In I; Jeong JH; Park SY
    ChemMedChem; 2018 Jul; 13(14):1459-1468. PubMed ID: 29774663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering Metal-Organic Frameworks for Photoacoustic Imaging-Guided Chemo-/Photothermal Combinational Tumor Therapy.
    Zhang Y; Wang L; Liu L; Lin L; Liu F; Xie Z; Tian H; Chen X
    ACS Appl Mater Interfaces; 2018 Dec; 10(48):41035-41045. PubMed ID: 30403471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifunctional Bi@PPy-PEG Core-Shell Nanohybrids for Dual-Modal Imaging and Photothermal Therapy.
    Yang S; Li Z; Wang Y; Fan X; Miao Z; Hu Y; Li Z; Sun Y; Besenbacher F; Yu M
    ACS Appl Mater Interfaces; 2018 Jan; 10(2):1605-1615. PubMed ID: 29272573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A core/shell/satellite anticancer platform for 808 NIR light-driven multimodal imaging and combined chemo-/photothermal therapy.
    Yang G; Lv R; He F; Qu F; Gai S; Du S; Wei Z; Yang P
    Nanoscale; 2015 Aug; 7(32):13747-58. PubMed ID: 26220401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paramagnetic CuS hollow nanoflowers for T
    Zhang H; Chen Y; Cai Y; Liu J; Liu P; Li Z; An T; Yang X; Liang C
    Biomater Sci; 2018 Dec; 7(1):409-418. PubMed ID: 30488900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
    Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
    Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.